Unknown

Dataset Information

0

Clinicopathological Characterization and Prognostic Implication of SMAD4 Expression in Colorectal Carcinoma.


ABSTRACT:

Background

SMAD family member 4 (SMAD4) has gained attention as a promising prognostic factor of colorectal cancer (CRC) as well as a key molecule to understand the tumorigenesis and progression of CRC.

Methods

We retrospectively analyzed 1,281 CRC cases immunohistochemically for their expression status of SMAD4, and correlated this status with clinicopathologic and molecular features of CRCs.

Results

A loss of nuclear SMAD4 was significantly associated with frequent lymphovascular and perineural invasion, tumor budding, fewer tumor-infiltrating lymphocytes, higher pT and pN category, and frequent distant metastasis. In contrast, tumors overexpressing SMAD4 showed a significant association with sporadic microsatellite instability. After adjustment for TNM stage, tumor differentiation, adjuvant chemotherapy, and lymphovascular invasion, the loss of SMAD4 was found to be an independent prognostic factor for worse 5-year progression-free survival (hazard ratio [HR], 1.27; 95% confidence interval [CI], 1.01 to 1.60; p=.042) and 7-year cancerspecific survival (HR, 1.45; 95% CI, 1.06 to 1.99; p=.022).

Conclusions

We confirmed the value of determining the loss of SMAD4 immunohistochemically as an independent prognostic factor for CRC in general. In addition, we identified some histologic and molecular features that might be clues to elucidate the role of SMAD4 in colorectal tumorigenesis and progression.

SUBMITTER: Yoo SY 

PROVIDER: S-EPMC6755646 | biostudies-literature | 2019 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Clinicopathological Characterization and Prognostic Implication of SMAD4 Expression in Colorectal Carcinoma.

Yoo Seung-Yeon SY   Lee Ji-Ae JA   Shin Yunjoo Y   Cho Nam-Yun NY   Bae Jeong Mo JM   Kang Gyeong Hoon GH  

Journal of pathology and translational medicine 20190624 5


<h4>Background</h4>SMAD family member 4 (SMAD4) has gained attention as a promising prognostic factor of colorectal cancer (CRC) as well as a key molecule to understand the tumorigenesis and progression of CRC.<h4>Methods</h4>We retrospectively analyzed 1,281 CRC cases immunohistochemically for their expression status of SMAD4, and correlated this status with clinicopathologic and molecular features of CRCs.<h4>Results</h4>A loss of nuclear SMAD4 was significantly associated with frequent lympho  ...[more]

Similar Datasets

| S-EPMC7326975 | biostudies-literature
| S-EPMC10636623 | biostudies-literature
| S-EPMC6366887 | biostudies-literature
| S-EPMC8025820 | biostudies-literature
| S-EPMC6831235 | biostudies-literature
| S-EPMC6977319 | biostudies-literature
| S-EPMC7782388 | biostudies-literature
| S-EPMC5610009 | biostudies-literature
| S-EPMC7464028 | biostudies-literature
| S-EPMC11362418 | biostudies-literature